INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2016

Soy isoflavone consumption was linked to a reduced risk of colorectal cancer, especially among Asian populations and in case-control studies.

A systematic review and meta-analysis of 17 epidemiologic studies (13 case-control and 4 prospective cohort studies) examined the association between soy isoflavone intake and colorectal cancer (CRC) risk. Soy isoflavone consumption was associated with reduced CRC risk (RR: 0.78, 95% CI: 0.72-0.85; I2 = 34.1%, P = 0.024). Subgroup analyses showed significant reductions for soy foods/products (RR: 0.79, 95% CI: 0.69-0.89), in Asian populations (RR: 0.79, 95% CI: 0.72-0.87), and in case-control studies (RR: 0.76, 95% CI: 0.68-0.84). The authors noted that other factors may affect this association due to the limited number of studies.

Shows an association, not proof of cause and effect.

Study type
Systematic review and meta-analysis of observational studies
Who was studied
Participants across 17 epidemiologic studies (13 case-control and 4 prospective cohort studies)
What was measured
Colorectal cancer (CRC) risk

THE PAPER

Soy isoflavone consumption and colorectal cancer risk: a systematic review and meta-analysis.

Yu Y, Jing X, Li H, Zhao X, Wang D. Sci Rep, 2016.

PubMed 27170217 ↗DOI 10.1038/srep25939 ↗

CancerGut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.